632
Participants
Start Date
July 31, 2006
Primary Completion Date
November 30, 2009
Study Completion Date
April 30, 2010
IMVAMUNE
Subjects receiving two subcutaneous vaccinations
Hospital General de México, Mexico City
Dermatology Associates of Rochester, Rochester
Hospital Angel Leañol, Dermatology, Zapopan, Jalisco
Northwestern University, Chicago
Saint Louis University, St Louis
Sundance Clinical Research, St Louis
"Centro Regional de Alergia e Inmunología Clínica del Hospital Universitario Dr. José Eleuterio González", Monterrey
Adult & Pediatric Dermatology PC, Overland Park
Meridian Clinical Research, Omaha
Burke Pharmaceutical Research, Hot Springs
Dermatology Treatment & Research Center, Dallas
Dermatology Clinical Research, San Antonio
Alta Clinical Research LLC, Tucson
Rx Clinical Research, Inc., Garden Grove
Solano Clinical Research, Vallejo
Oregon Dermatology & Research Center, Portland
University of Kentucky Medical Center, Lexington
Academic Dermatology Associates, Albuquerque
Hospital Juárez de México, Magdalena de las Salinas
"Instituto Dermatologico de Jalisco Dr. Jose Barba Rubio", Guadalajara
CIFBIOTEC (Centro de Investigacion Farmacologica y Biotecnologica), Mexico City
Hospital Regional Lic. Adolfo Lopez Mateos. ISSSTE Ciudad de Mexico, Mexico City
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Bavarian Nordic
INDUSTRY